TEV 48317
Alternative Names: TEV-48317Latest Information Update: 11 Jun 2024
At a glance
- Originator Teva Pharmaceutical Industries
- Class Small molecules
- Mechanism of Action Fatty acid synthetase complex inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Unspecified